Last update:

Weight management news

The connection between high-fat ketogenic diets and weight loss

Ketogenic diets have attracted enormous attention for their purported health benefits, particularly their ability to promote weight loss. Despite their popularity, studies investigating the composition of these high-fat, ...

Sugar made by gut bacterium may help the body burn visceral fat

Scientists have discovered that a sugar produced by a gut bacterium can increase energy burning in visceral fat—the harmful fat that accumulates around internal organs—while reducing weight gain and improving metabolic health, ...

Two measures to help prevent obesity in young people

Obesity in children and young people increases the risk of health problems later in life to such an extent that tackling it is important, both for individuals and for the population as a whole. The condition is generally ...

Five things that shape body weight—by an obesity expert

What you eat when you're tired and hungry might come down to what's open on the way home and what you can afford. Both appetite and access to food shape decisions that can look, from the outside, like simple matters of choice.

Why don't GLP‑1 obesity drugs work for everyone?

Medications like Ozempic and Wegovy, which contain semaglutide—a GLP‑1 receptor agonist that helps regulate blood sugar, appetite and body weight—have become household names and important pillars in obesity management for ...

Weekly weight-loss injection combo shows promise

Two lower doses of CagriSema, a weekly injection combining two appetite-reducing medicines, cagrilintide and semaglutide, led to substantial weight loss in adults with obesity or with overweight and a weight-related health ...

RNA switch lets drugs control gene therapy protein production

Bioengineers at the University of California San Diego have developed a technology that allows drugs to control when cells produce therapeutic proteins, which could potentially make gene therapies safer and more adaptable ...

China approves first oral GLP-1 weight-loss pill

China has approved its first orally administered GLP-1 weight-loss drug, permitting Eli Lilly to sell its orforglipron pill in a market where 630 million adults could be overweight or obese by 2050.